Ardelyx Inc.
Ardelyx is dedicated to creating a healthier tomorrow by delivering first-in-class medicines to patients with unmet medical needs. The company focuses on therapeutic areas such as chronic kidney disease with hyperphosphatemia and irritable bowel syndrome with constipation, working closely with patients, caregivers, and healthcare professionals to improve outcomes and set new standards in patient care, community engagement, and product innovation.
Industries
Nr. of Employees
medium (51-250)
Ardelyx Inc.
Products
IBSRELA
Approved oral therapy for the treatment of irritable bowel syndrome with constipation (IBS-C) in indicated populations; prescribing information and boxed warning available in official product documentation.
XPHOZAH
Approved therapy for the improvement of hyperphosphatemia in adult patients with chronic kidney disease on dialysis; prescribing information available.
Patient access and support program (digital)
A patient services program providing access, affordability, and care-coordination support for patients prescribed company medicines, delivered via digital tools and phone support.
IBSRELA
Approved oral therapy for the treatment of irritable bowel syndrome with constipation (IBS-C) in indicated populations; prescribing information and boxed warning available in official product documentation.
XPHOZAH
Approved therapy for the improvement of hyperphosphatemia in adult patients with chronic kidney disease on dialysis; prescribing information available.
Patient access and support program (digital)
A patient services program providing access, affordability, and care-coordination support for patients prescribed company medicines, delivered via digital tools and phone support.
Services
Digital patient services and access program
A digital-forward, high-touch program that provides patient access and affordability support and integrates with medical office workflows and provider communications.
Clinical trial enrollment and trial information
Provision of information for patients and healthcare professionals about ongoing clinical trials and pathways for patient participation.
Educational and charitable grant programs
Selective funding and grants for independent medical education and community or healthcare-related charitable organizations, managed via a grants portal and internal review procedures.
Partnering and out-licensing for regional commercialization
Structuring and managing licensing agreements for development and commercialization in territories outside the primary market.
Digital patient services and access program
A digital-forward, high-touch program that provides patient access and affordability support and integrates with medical office workflows and provider communications.
Clinical trial enrollment and trial information
Provision of information for patients and healthcare professionals about ongoing clinical trials and pathways for patient participation.
Educational and charitable grant programs
Selective funding and grants for independent medical education and community or healthcare-related charitable organizations, managed via a grants portal and internal review procedures.
Partnering and out-licensing for regional commercialization
Structuring and managing licensing agreements for development and commercialization in territories outside the primary market.
Expertise Areas
- Mechanism-based small-molecule drug discovery
- Early drug development and IND/NDA preparation
- Clinical trial management and patient recruitment
- Commercialization and market access for specialty therapeutics
Key Technologies
- Mechanism-driven small-molecule discovery
- Non-absorbed/minimally systemic small-molecule therapeutics
- Digital patient services platform
- Clinical trial management systems